Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a major
public health problem worldwide. Hepatocarcinogenesis is a complex multistep process at …

In oncology, staging forms the basis for prognostic consideration and directly influences
patient care by determining the therapeutic approach. Cross-sectional imaging techniques …

Purpose This study aimed to compare the performance of 68 Ga-labelled fibroblast
activating protein inhibitor (FAPI) PET and 18 F-FDG PET for imaging of hepatic tumours …

We compared 18 F-fluorocholine hybrid positron emission tomography/X-ray computed
tomography (FCH-PET/CT) with ultrasonography (US) and scintigraphy in patients with …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide and one of the most common causes of death among patients with cirrhosis …

Context: Preoperative ultrasonography and scintigraphy using 99mTc-sestamibi are
commonly used to localize abnormal parathyroid glands. In cases of discrepant results …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality worldwide.
Various imaging modalities provide important information about HCC for its clinical …

Purpose In this prospective study, our goal was to emphasize the diagnostic value of
combining 11 C-choline and 18 F-FDG PET/CT for hepatocellular carcinoma (HCC) in …

The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for
hepatocellular carcinoma (HCC) constitute an evidence-and consensus-based instrument …

Purpose Hexokinase-2 (HK2) and more recently choline kinase alpha (CKA) expression has
been correlated with clinical outcomes in several major cancers. This study examines the …